In conclusion, our study demonstrates that DPP4 deficiency and remote ischemic preconditioning protect kidneys from acute IR injury by elevating circulating GLP-1 levels and represent potential therapeutic targets for acute kidney injury, especially in type 2 diabetic patients. Here, GLP1R is linked to acute kidney injury.